Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 0406-1850

10 FDA label images from Specgx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 0406-1850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylphenidate Hydrochloride Er Capsules 1)

Chemical Structure (Methylphenidate Hydrochloride Er Capsules  1)
Chemical structure of methylphenidate hydrochloride, showing its molecular arrangement including a phenyl ring, piperidine ring, ester group, and hydrochloride component.*
FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Er Capsules 2)

Figure 1 (Methylphenidate Hydrochloride Er Capsules  2)
A pharmacokinetic line graph depicting mean methylphenidate plasma concentration (ng/mL) over 9 hours post dosing. It compares single doses of 10 mg immediate-release (IR) at 0 and 4 hours, 20 mg methylphenidate hydrochloride extended-release (ER) capsules, and two 20 mg methylphenidate HCl ER capsules. The x-axis shows time after dosing (hours) and the y-axis shows mean methylphenidate concentration.*
FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Er Capsules 3)

Figure 2 (Methylphenidate Hydrochloride Er Capsules  3)
A bar chart comparing the least squares mean change from baseline between Methylphenidate Hydrochloride Extended-Release Capsules (n=155) and placebo (n=159). The Methylphenidate group shows a larger decrease around -7.9, while the placebo group shows a smaller decrease around -1.2, with error bars indicating variability.*
FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Er Capsules 4)

Figure 3 (Methylphenidate Hydrochloride Er Capsules  4)
A bar chart showing LS Mean Change from Baseline comparing Methylphenidate Hydrochloride Extended-Release Capsules and placebo in AM and PM time periods. Bars represent average changes for each group, with error bars indicating variability. Methylphenidate group shows larger negative change values than placebo in both AM and PM.*
FDA Label Image

Principal Display Panel 10 mg Label (Methylphenidate Hydrochloride Er Capsules 5)

Principal Display Panel 10 mg Label (Methylphenidate Hydrochloride Er Capsules  5)
Label for Methylphenidate Hydrochloride Extended-Release Capsules 10 mg by SpecGx LLC, containing 100 capsules. The label shows the NDC 0406-1810-01 and includes medication instructions, storage conditions, and pharmacist dispensing information. The capsule image is green and tan with imprint "M 1810" and strength 10 mg.*
FDA Label Image

Principal Display Panel 20 mg Label (Methylphenidate Hydrochloride Er Capsules 6)

Principal Display Panel 20 mg Label (Methylphenidate Hydrochloride Er Capsules  6)
Label for Methylphenidate Hydrochloride Extended-Release Capsules 20 mg, once daily dosage. The label indicates a package of 100 capsules, Rx only, manufactured by SpecGx LLC. It includes storage instructions, a pharmacist dispensing note, and a barcode. Capsule imprint and strength details are also shown.*
FDA Label Image

Principal Display Panel 30 mg Label (Methylphenidate Hydrochloride Er Capsules 7)

Principal Display Panel 30 mg Label (Methylphenidate Hydrochloride Er Capsules  7)
Label of Methylphenidate Hydrochloride Extended-Release Capsules 30 mg by SpecGx LLC. The package contains 100 capsules. The label includes the drug's name, strength, dosage form, NDC 0406-1830-01, and directions noting it is for Rx only and taken once daily. Additional information about dosage, storage, and manufacturer location in Webster Groves, MO is also shown.*
FDA Label Image

Principal Display Panel 40 mg Label (Methylphenidate Hydrochloride Er Capsules 8)

Principal Display Panel 40 mg Label (Methylphenidate Hydrochloride Er Capsules  8)
Methylphenidate Hydrochloride Extended-Release 40 mg capsule packaging label showing a box with 100 capsules. The label includes dosage form as extended-release capsules, strength 40 mg, Rx only designation, and instructions for pharmacists to dispense the Medication Guide. The label also provides storage instructions, dosage warnings, and manufacturer information for SpecGx LLC, Webster Groves, MO. An image of a capsule marked with 40 mg is visible.*
FDA Label Image

Principal Display Panel 50 mg Label (Methylphenidate Hydrochloride Er Capsules 9)

Principal Display Panel 50 mg Label (Methylphenidate Hydrochloride Er Capsules  9)
Label for Methylphenidate Hydrochloride Extended-Release Capsules 50 mg by SpecGx LLC. The label indicates 100 capsules per package, for oral use, with instructions to dispense the Medication Guide to patients. Storage and dosage instructions are listed along with the manufacturer details in Webster Groves, MO.*
FDA Label Image

Principal Display Panel 60 mg Label (Methylphenidate Hydrochloride Er Capsules 10)

Principal Display Panel 60 mg Label (Methylphenidate Hydrochloride Er Capsules  10)
Label for Methylphenidate Hydrochloride Extended-Release Capsules 60 mg, oral capsule, Rx only, manufactured by SpecGx LLC. The label indicates a package of 100 capsules and includes dispensing instructions, storage conditions, and a barcode. The capsule image shows a white and beige capsule marked with "160 60 mg."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.